HOME SLTNS HEALTH INC by Home Solutions Health, Inc. Analyst Ratings and Price Targets | OTC:HSHL | Benzinga

HOME SLTNS HEALTH INC by Home Solutions Health, Inc. Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for HOME SLTNS HEALTH INC by Home Solutions Health, Inc. Corp from these most-recent analyst ratings.

Analyst Ratings for HOME SLTNS HEALTH INC by Home Solutions Health, Inc.

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for HOME SLTNS HEALTH INC by Home Solutions Health, Inc. (HSHL) stock?

A

There is no price target for HOME SLTNS HEALTH INC by Home Solutions Health, Inc.

Q

What is the most recent analyst rating for HOME SLTNS HEALTH INC by Home Solutions Health, Inc. (HSHL)?

A

There is no analyst for HOME SLTNS HEALTH INC by Home Solutions Health, Inc.

Q

When was the last upgrade for HOME SLTNS HEALTH INC by Home Solutions Health, Inc. (HSHL)?

A

There is no last upgrade for HOME SLTNS HEALTH INC by Home Solutions Health, Inc.

Q

When was the last downgrade for HOME SLTNS HEALTH INC by Home Solutions Health, Inc. (HSHL)?

A

There is no last downgrade for HOME SLTNS HEALTH INC by Home Solutions Health, Inc..

Q

When is the next analyst rating going to be posted or updated for HOME SLTNS HEALTH INC by Home Solutions Health, Inc. (HSHL)?

A

There is no next analyst rating for HOME SLTNS HEALTH INC by Home Solutions Health, Inc..

Q

Is the Analyst Rating HOME SLTNS HEALTH INC by Home Solutions Health, Inc. (HSHL) correct?

A

There is no next analyst rating for HOME SLTNS HEALTH INC by Home Solutions Health, Inc..

Browse analyst ratings and price targets on all stocks.